Sunday November 19th 2017

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis

Abstract: Fingolimod has demonstrated efficacy in patients with multiple sclerosis (MS), and patients become gradually lymphopenic after a few days of treatment, with selective reductions in CD4+ subsets. We observed an increase in the frequencies of circulating regulatory T cells after fingolimod administration. However, we also found that half of patients had increased proportion of circulating Th17 cells in CD4+ T cells after treatment (including a patient with MS relapses), whereas the others showed lower frequencies of Th17 cells, indicating some variability among patients. Further studies may confirm if slower reduction of circulating Th17 cells following fingolimod initiation predisposes to relapses. (Source: Journal of Neuroimmunology)

Visit link – 

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis

Leave a Comment

More from category

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age [Read More]

Age and gut bacteria contribute to MS disease progression, according to Rutgers
Age and gut bacteria contribute to MS disease progression, according to Rutgers

(Rutgers University) Gut bacteria at a young age can contribute to multiple sclerosis disease onset and progression. [Read More]

Virtual reality training may be effective alternative to standard therapy after stroke
Virtual reality training may be effective alternative to standard therapy after stroke

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular [Read More]

Social care failing people with disabilities, says leading charity
Social care failing people with disabilities, says leading charity

Young people with MS forced to live in care homes for older people Related items fromOnMedica Social care set to eat up [Read More]

World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle
World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle

/About-the-Society/News/World’s-Largest-MS-Research-Conference-Features-Ad [Read More]